Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data-Reference-Cited by-同舟云学术

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

Published:2019-02 Issue:1 Volume:41 Page:59-65
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Daskapan Alper,Tran Quynh T.D.,Cattaneo Dario,Gervasoni Cristina,Resnati Chiara,Stienstra Ymkje,Bierman Wouter F.W.,Kosterink Jos G. W.,van der Werf Tjip S.,Proost Johannes H.,Alffenaar Jan-Willem C.,Touw Daniel J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir;Kakuda;J Antimicrob Chemother.,2014

2. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals;Arab-Alameddine;J Antimicrob Chemother.,2014

3. Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers;Kakuda;Antivir Ther.,2014

4. Clinical pharmacokinetics of darunavir;Rittweger;Clin Pharmacokinet.,2007

5. Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): week 48 subgroup analysis of HIV-1-infected treatment-nave adults;Tashima;J Int AIDS Soc.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages;Experimental Biology and Medicine;2024-07-25

2. The influence of single nucleotide polymorphisms on the therapeutic effect of antiretroviral drugs;Medicinski podmladak;2024

3. PBPK Model Simulation study on Impact of Captrophil for Renal Impairment patients(RI);2022 IEEE 7th International conference for Convergence in Technology (I2CT);2022-04-07

4. Literature Review on Estimation of Drug Parameters Using Physiologically-Based Pharmacokinetic Modeling;Journal of Physics: Conference Series;2021-06-01

5. The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV;Expert Opinion on Drug Metabolism & Toxicology;2021-04-29